Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BNGO

Bionano Genomics, Inc.

Healthcare · USD

Set alert

Price alert · BNGO

All alert types
1.15 USD -0.05 -4.17%
As of Oct 30, 2026 Extended hours 1.19 +3.48%
Bid
1.15 × 1
Ask
1.16 × 1
1.12 Day range 1.20
1.06 52-week range 1.85
YTD
-24.84%
1 year
-35.75%
Open
1.20
Prev close
1.20
Mkt cap
16.07M
Vol
196.43K
Avg vol
945.92K
EPS
-3.02
P/E
0.00
Div yield
0.00%
More statistics
Low
1.12
High
1.20
Forward P/E
-0.41
Beta
2.38
Short ratio
3.81
Inst. own
12.81%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
0.2652
200-d avg
0.6133
1y target
1.00

5D chart

Chart tools
Interval
1m5m15m30m
BNGO five-day price chart1.101.141.181.211.25Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-22.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2016: -3.3×FY 2017: -2.6×FY 2018: -2.0×FY 2019: -0.6×FY 2020: -7.8×FY 2021: -11.4×FY 2022: -3.2×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.3× FY 2025
P/S 0.3×
FY 2016: 9.0×FY 2017: 6.5×FY 2018: 3.1×FY 2019: 1.8×FY 2020: 37.8×FY 2021: 46.0×FY 2022: 15.2×FY 2023: 1.8×FY 2024: 0.7×FY 2025: 0.3×
FY 2016 5y median 1.8× FY 2025
P/B 0.2×
FY 2016: -2.3×FY 2017: -1.2×FY 2018: 3.7×FY 2019: 5.1×FY 2020: 9.2×FY 2021: 2.5×FY 2022: 1.7×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.7× FY 2025
P/FCF -0.5×
FY 2016: -2.5×FY 2017: -2.8×FY 2018: -1.8×FY 2019: -0.6×FY 2020: -8.4×FY 2021: -11.3×FY 2022: -3.3×FY 2023: -0.5×FY 2024: -0.3×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
EV/EBITDA -0.8×
FY 2016: -3.6×FY 2017: -3.2×FY 2018: -1.9×FY 2019: -0.8×FY 2020: -8.4×FY 2021: -11.0×FY 2022: -3.6×FY 2023: -0.6×FY 2024: -0.4×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
EV/Sales 0.4×
FY 2016: 9.3×FY 2017: 7.1×FY 2018: 2.5×FY 2019: 2.1×FY 2020: 35.2×FY 2021: 45.3×FY 2022: 15.4×FY 2023: 3.5×FY 2024: 1.3×FY 2025: 0.4×
FY 2016 5y median 3.5× FY 2025
FCF Yield -196.2%
FY 2016: -40.4%FY 2017: -35.5%FY 2018: -54.7%FY 2019: -159.3%FY 2020: -11.9%FY 2021: -8.9%FY 2022: -30.3%FY 2023: -196.6%FY 2024: -313.9%FY 2025: -196.2%
FY 2016 5y median -196.2% FY 2025

Profitability

Gross Margin 22.0%
FY 2016: 47.3%FY 2017: 36.6%FY 2018: 27.4%FY 2019: 33.2%FY 2020: 32.6%FY 2021: 21.5%FY 2022: 21.4%FY 2023: 26.5%FY 2024: 1.2%FY 2025: 22.0%
FY 2016 5y median 21.5% FY 2025
Operating Margin -116.9%
FY 2016: -311.6%FY 2017: -244.3%FY 2018: -170.1%FY 2019: -255.4%FY 2020: -453.4%FY 2021: -428.8%FY 2022: -473.7%FY 2023: -596.0%FY 2024: -337.9%FY 2025: -116.9%
FY 2016 5y median -428.8% FY 2025
Net Margin -92.6%
FY 2016: -277.5%FY 2017: -245.8%FY 2018: -154.1%FY 2019: -294.3%FY 2020: -483.4%FY 2021: -402.8%FY 2022: -476.9%FY 2023: -643.7%FY 2024: -364.0%FY 2025: -92.6%
FY 2016 5y median -402.8% FY 2025
ROE -59.4%
FY 2016: 69.1%FY 2017: 46.5%FY 2018: -182.5%FY 2019: -825.1%FY 2020: -117.2%FY 2021: -21.5%FY 2022: -53.2%FY 2023: -241.8%FY 2024: -316.7%FY 2025: -59.4%
FY 2016 5y median -59.4% FY 2025
ROIC -64.6%
FY 2016: -352.2%FY 2017: -10428.2%FY 2018: -100.7%FY 2019: -108.1%FY 2020: -74.8%FY 2021: -20.0%FY 2022: -48.0%FY 2023: -115.3%FY 2024: -165.2%FY 2025: -64.6%
FY 2016 5y median -64.6% FY 2025
ROA -35.9%
FY 2016: -127.5%FY 2017: -230.3%FY 2018: -74.6%FY 2019: -98.7%FY 2020: -68.0%FY 2021: -19.2%FY 2022: -43.1%FY 2023: -108.4%FY 2024: -146.1%FY 2025: -35.9%
FY 2016 5y median -43.1% FY 2025

Growth (YoY)

Revenue -7.4%
FY 2016: 0.0%FY 2017: 39.9%FY 2018: 26.3%FY 2019: -15.6%FY 2020: -16.1%FY 2021: 111.5%FY 2022: 54.6%FY 2023: 29.9%FY 2024: -14.8%FY 2025: -7.4%
FY 2016 FY 2025
Operating Income 67.9%
FY 2016: 0.0%FY 2017: -9.7%FY 2018: 12.1%FY 2019: -26.7%FY 2020: -49.0%FY 2021: -100.0%FY 2022: -70.8%FY 2023: -63.4%FY 2024: 51.7%FY 2025: 67.9%
FY 2016 FY 2025
EPS (diluted) 94.5%
FY 2016: 0.0%FY 2017: -24.0%FY 2018: -11.8%FY 2019: 23.8%FY 2020: 80.2%FY 2021: 33.6%FY 2022: -75.2%FY 2023: -48.5%FY 2024: 78.4%FY 2025: 94.5%
FY 2016 FY 2025
Free Cash Flow 76.3%
FY 2016: 0.0%FY 2017: 12.1%FY 2018: 7.1%FY 2019: -45.9%FY 2020: -29.5%FY 2021: -91.5%FY 2022: -74.6%FY 2023: 1.0%FY 2024: 45.6%FY 2025: 76.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.0×
FY 2016: 1.1×FY 2017: 0.4×FY 2018: 5.1×FY 2019: 1.1×FY 2020: 5.2×FY 2021: 12.5×FY 2022: 4.4×FY 2023: 1.4×FY 2024: 1.1×FY 2025: 2.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 1.7×
FY 2016: 1.0×FY 2017: 0.3×FY 2018: 4.9×FY 2019: 0.9×FY 2020: 4.9×FY 2021: 11.9×FY 2022: 3.6×FY 2023: 1.2×FY 2024: 0.8×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.2×
FY 2016: -0.2×FY 2017: -0.1×FY 2018: 0.9×FY 2019: 5.6×FY 2020: 0.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: -0.1×FY 2017: -0.3×FY 2018: 0.5×FY 2019: -0.1×FY 2020: 0.6×FY 2021: 0.2×FY 2022: -0.1×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -112×
FY 2016: -45.0×FY 2017: -39.3×FY 2018: -14.8×FY 2019: -11.3×FY 2020: -15.3×FY 2021: -83.2×FY 2022: -442×FY 2023: -42.0×FY 2024: -360×FY 2025: -112×
FY 2016 5y median -112× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31